Sfoglia per Autore
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development
2011-01-01 Svicher, Valentina; Cento, Valeria; Salpini, Romina; Mercurio, Fabio; Fraune, Maria; Beggel, Bastian; Han, Yue; Gori, Caterina; Wittkop, Linda; Bertoli, Ada; Micheli, Valeria; Gubertini, Guido; Longo, Roberta; Romano, Sara; Visca, Michela; Gallinaro, Valentina; Marino, Nicoletta; Mazzotta, Francesco; De Sanctis, Giuseppe Maria; Fleury, Hervè; Trimoulet, Pascale; Angelico, Mario; Cappiello, Giuseppina; Zhang, Xin Xin; Verheyen, Jens; Ceccherini-Silberstein, Francesca; Perno, Carlo Federico
Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology
2011-01-01 Cento, Valeria; Rahmatalla, Noor; Ciccozzi, Massimo; Perno, Carlo Federico; Ciotti, Marco
Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon
2011-01-01 Fokam, Joseph; Salpini, Romina; Santoro, Maria Mercedes; Cento, Valeria; Perno, Carlo-Federico; Colizzi, Vittorio; Ndumbe, Peter Martins; Fokunang Ntungen, Charles; Ndiang Tetang, Suzie Moyo; Nanfack, Aubin Joseph; Takou Komego, Désiré Augustin; Cappelli, Giulia
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro
2011-01-01 Svicher, Valentina; Balestra, Emanuela; Cento, Valeria; Sarmati, Loredana; Dori, Luca; Vandenbroucke, Ina; D'Arrigo, Roberta; Buonomini, Anna Rita; Van Marck, Herwig; Surdo, Matteo; Saccomandi, Patrizia; Mostmans, Wendy; Aerssens, Jeroen; Aquaro, Stefano; Stuyver, Lieven J; Andreoni, Massimo; Ceccherini-Silberstein, Francesca; Perno, Carlo Federico
NOVEL REVERSE TRANSCRIPTASE MUTATIONS SPECIFICALLY ASSOCIATED WITH SELECTED ANTI-HBV TREATMENT CAN INDUCE ALTERATIONS AND STOP-CODONS IN HBV S ANTIGEN
2012-01-01 Cento, V; Van Hemert, F; Di Maio, Vc; Salpini, R; Mirabelli, C; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; De Sanctis, Gm; Marino, N; Mazzotta, F; Cappiello, G; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf; Svicher, V
KEY PATTERNS OF HBX AND PRE-S1/S2 MUTATIONS ARE INVOLVED IN MECHANISMS UNDERLYING HBV-INDUCED HEPATOCELLULAR CARCINOMA IN VIVO
2012-01-01 Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, Vc; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf
NS3 and NS5A genotypes variants correlate with slow or fast progression of HCV-related disease after liver transplantation: does the viral diversity play really a role on fibrosis progression?
2012-01-01 Lenci, I; Cucchiarelli, S; Di Maio, C; Cento, V; Milano, M; Di Paolo, D; De Luca, F; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing
2012-01-01 Armenia, Daniele; Vandenbroucke, Ina; Fabeni, Lavinia; Van Marck, Herwig; Cento, Valeria; D'Arrigo, Roberta; Van Wesenbeeck, Liesbeth; Scopelliti, Fernanda; Micheli, Valeria; Bruzzone, Bianca; Lo Caputo, Sergio; Aerssens, Jeroen; Rizzardini, Giuliano; Tozzi, Valerio; Narciso, Pasquale; Antinori, Andrea; Stuyver, Lieven; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors
2012-01-01 Cento, Valeria; Mirabelli, Carmen; Salpini, Romina; Dimonte, Salvatore; Artese, Anna; Costa, Giosuè; Mercurio, Fabio; Svicher, Valentina; Parrotta, Lucia; Bertoli, Ada; Ciotti, Marco; Di Paolo, Daniele; Sarrecchia, Cesare; Andreoni, Massimo; Alcaro, Stefano; Angelico, Mario; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection
2012-01-01 Svicher, Valentina; Cento, Valeria; Bernassola, Martina; Neumann-Fraune, Maria; Van Hemert, Formijn; Chen, Mengjie; Salpini, Romina; Liu, Chang; Longo, Roberta; Visca, Michela; Romano, Sara; Micheli, Valeria; Bertoli, Ada; Gori, Caterina; Ceccherini-Silberstein, Francesca; Sarrecchia, Cesare; Andreoni, Massimo; Angelico, Mario; Ursitti, Antonella; Spanò, Alberto; Zhang, Jing Maria; Verheyen, Jens; Cappiello, Giuseppina; Perno, Carlo Federico
Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon
2012-01-01 Ceccarelli, Laura; Salpini, Romina; Moudourou, Sylvie; Cento, Valeria; Santoro, Maria M; Fokam, Joseph; Takou, Desire; Nanfack, Aubin; Dori, Luca; Torimiro, Judith; Sarmati, Loredana; Andreoni, Massimo; Perno, Carlo F; Colizzi, Vittorio; Cappelli, Giulia
Human papillomaviruses 53 and 66: clinical aspects and genetic analysis
2012-01-01 Cento, Valeria; Rahmatalla, Noor; Ciccozzi, Massimo; Lo Presti, Alessandra; Perno, Carlo Federico; Ciotti, Marco
Early detection of NS3-resistance in HCV patients with advanced disease treated with BOC/TVR-based therapy: analysis by population- and ultra-deep sequencing
2013-01-01 Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Carioti, L; Fortuna, S; Bertoli, A; De Luca, F; De Leonardis, F; Madeddu, G; Navarra, P; Magni, C; Sarrecchia, C; Babudieri, S; Siciliano, M; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F
CORRELATION OF EARLY DETECTION OF HCV NS3-RESISTANCE AND VIROLOGICAL FAILURE IN PATIENTS TREATED WITH TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR
2013-01-01 Cento, V; Di Maio, Vc; Di Paolo, D; De Luca, F; Micheli, V; Tontodonati, M; Bellocchi, Mc; Carioti, L; Armenia, D; De Leonardis, F; Antonucci, Fp; Madeddu, G; Magni, C; Sarrecchia, C; Babudieri, S; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F
HIGH RATES OF HBsAg "a DETERMINANT" VARIABILITY AND IMMUNE ESCAPE MUTATIONS ARE ASSOCIATED WITH HBV REACTIVATION UPON IMMUNOSUPPRESSIVE THERAPY
2013-01-01 Salpini, R; Alteri, C; Cento, V; Ricciardi, A; Maffongelli, G; Pollicita, M; Mirabelli, C; Sarrecchia, C; Sarmati, L; Mastroianni, C; Paoloni, M; Angelico, M; Andreoni, M; Perno, Cf; Svicher, V
KEY GENETIC SIGNATURES IN THE WHOLE pre-S1/Pre-S2/S GENE CORRELATE WITH HBV-INDUCED CARCINOGENESIS BY AFFECTING HBsAg SECRETION AND RELEASE
2013-01-01 Svicher, V; Neumann-Fraune, M; Mirabelli, C; Salpini, R; Cento, V; Di Maio, Vc; Bertoli, A; Alteri, C; Aragri, M; Gori, C; Micheli, V; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf
Key genetic markers in the full-length HBsAg gene correlate with HBV-driven carcinogenesis by affecting HBsAg secretion and release
2013-01-01 Svicher, V; Neumann-Fraune, M; Mirabelli, C; Salpini, R; Cento, V; Di Maio, Vc; Bertoli, A; Alteri, C; Aragri, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Verhejen, J; Perno, Cf
Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure
2013-01-01 Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf
HCV DIVERSITY AND FIBROSIS PROGRESSION: NS5A AND CORE VARIANTS CORRELATE WITH SEVERITY OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION
2013-01-01 Lenci, I; Cucchiarelli, S; Di Maio, Vc; Cento, V; De Luca, F; Milana, M; Antonucci, Fp; Di Paolo, D; Giardina, E; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
NS3-resistance in advanced HCV patients treated with BOC/TRV-based therapy: impact on virological failure of baseline and early time points
2013-01-01 Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Bertoli, A; De Leonardis, F; Madeddu, G; Magni, C; Sarrecchia, C; Nosotti, L; Tortora, A; Di Biagio, A; Nicolini, La; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development | 1-gen-2011 | Svicher, Valentina; Cento, Valeria; Salpini, Romina; Mercurio, Fabio; Fraune, Maria; Beggel, Bastian; Han, Yue; Gori, Caterina; Wittkop, Linda; Bertoli, Ada; Micheli, Valeria; Gubertini, Guido; Longo, Roberta; Romano, Sara; Visca, Michela; Gallinaro, Valentina; Marino, Nicoletta; Mazzotta, Francesco; De Sanctis, Giuseppe Maria; Fleury, Hervè; Trimoulet, Pascale; Angelico, Mario; Cappiello, Giuseppina; Zhang, Xin Xin; Verheyen, Jens; Ceccherini-Silberstein, Francesca; Perno, Carlo Federico | |
| Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology | 1-gen-2011 | Cento, Valeria; Rahmatalla, Noor; Ciccozzi, Massimo; Perno, Carlo Federico; Ciotti, Marco | |
| Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon | 1-gen-2011 | Fokam, Joseph; Salpini, Romina; Santoro, Maria Mercedes; Cento, Valeria; Perno, Carlo-Federico; Colizzi, Vittorio; Ndumbe, Peter Martins; Fokunang Ntungen, Charles; Ndiang Tetang, Suzie Moyo; Nanfack, Aubin Joseph; Takou Komego, Désiré Augustin; Cappelli, Giulia | |
| HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro | 1-gen-2011 | Svicher, Valentina; Balestra, Emanuela; Cento, Valeria; Sarmati, Loredana; Dori, Luca; Vandenbroucke, Ina; D'Arrigo, Roberta; Buonomini, Anna Rita; Van Marck, Herwig; Surdo, Matteo; Saccomandi, Patrizia; Mostmans, Wendy; Aerssens, Jeroen; Aquaro, Stefano; Stuyver, Lieven J; Andreoni, Massimo; Ceccherini-Silberstein, Francesca; Perno, Carlo Federico | |
| NOVEL REVERSE TRANSCRIPTASE MUTATIONS SPECIFICALLY ASSOCIATED WITH SELECTED ANTI-HBV TREATMENT CAN INDUCE ALTERATIONS AND STOP-CODONS IN HBV S ANTIGEN | 1-gen-2012 | Cento, V; Van Hemert, F; Di Maio, Vc; Salpini, R; Mirabelli, C; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; De Sanctis, Gm; Marino, N; Mazzotta, F; Cappiello, G; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf; Svicher, V | |
| KEY PATTERNS OF HBX AND PRE-S1/S2 MUTATIONS ARE INVOLVED IN MECHANISMS UNDERLYING HBV-INDUCED HEPATOCELLULAR CARCINOMA IN VIVO | 1-gen-2012 | Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, Vc; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf | |
| NS3 and NS5A genotypes variants correlate with slow or fast progression of HCV-related disease after liver transplantation: does the viral diversity play really a role on fibrosis progression? | 1-gen-2012 | Lenci, I; Cucchiarelli, S; Di Maio, C; Cento, V; Milano, M; Di Paolo, D; De Luca, F; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing | 1-gen-2012 | Armenia, Daniele; Vandenbroucke, Ina; Fabeni, Lavinia; Van Marck, Herwig; Cento, Valeria; D'Arrigo, Roberta; Van Wesenbeeck, Liesbeth; Scopelliti, Fernanda; Micheli, Valeria; Bruzzone, Bianca; Lo Caputo, Sergio; Aerssens, Jeroen; Rizzardini, Giuliano; Tozzi, Valerio; Narciso, Pasquale; Antinori, Andrea; Stuyver, Lieven; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca | |
| HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors | 1-gen-2012 | Cento, Valeria; Mirabelli, Carmen; Salpini, Romina; Dimonte, Salvatore; Artese, Anna; Costa, Giosuè; Mercurio, Fabio; Svicher, Valentina; Parrotta, Lucia; Bertoli, Ada; Ciotti, Marco; Di Paolo, Daniele; Sarrecchia, Cesare; Andreoni, Massimo; Alcaro, Stefano; Angelico, Mario; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca | |
| Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection | 1-gen-2012 | Svicher, Valentina; Cento, Valeria; Bernassola, Martina; Neumann-Fraune, Maria; Van Hemert, Formijn; Chen, Mengjie; Salpini, Romina; Liu, Chang; Longo, Roberta; Visca, Michela; Romano, Sara; Micheli, Valeria; Bertoli, Ada; Gori, Caterina; Ceccherini-Silberstein, Francesca; Sarrecchia, Cesare; Andreoni, Massimo; Angelico, Mario; Ursitti, Antonella; Spanò, Alberto; Zhang, Jing Maria; Verheyen, Jens; Cappiello, Giuseppina; Perno, Carlo Federico | |
| Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon | 1-gen-2012 | Ceccarelli, Laura; Salpini, Romina; Moudourou, Sylvie; Cento, Valeria; Santoro, Maria M; Fokam, Joseph; Takou, Desire; Nanfack, Aubin; Dori, Luca; Torimiro, Judith; Sarmati, Loredana; Andreoni, Massimo; Perno, Carlo F; Colizzi, Vittorio; Cappelli, Giulia | |
| Human papillomaviruses 53 and 66: clinical aspects and genetic analysis | 1-gen-2012 | Cento, Valeria; Rahmatalla, Noor; Ciccozzi, Massimo; Lo Presti, Alessandra; Perno, Carlo Federico; Ciotti, Marco | |
| Early detection of NS3-resistance in HCV patients with advanced disease treated with BOC/TVR-based therapy: analysis by population- and ultra-deep sequencing | 1-gen-2013 | Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Carioti, L; Fortuna, S; Bertoli, A; De Luca, F; De Leonardis, F; Madeddu, G; Navarra, P; Magni, C; Sarrecchia, C; Babudieri, S; Siciliano, M; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F | |
| CORRELATION OF EARLY DETECTION OF HCV NS3-RESISTANCE AND VIROLOGICAL FAILURE IN PATIENTS TREATED WITH TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR | 1-gen-2013 | Cento, V; Di Maio, Vc; Di Paolo, D; De Luca, F; Micheli, V; Tontodonati, M; Bellocchi, Mc; Carioti, L; Armenia, D; De Leonardis, F; Antonucci, Fp; Madeddu, G; Magni, C; Sarrecchia, C; Babudieri, S; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F | |
| HIGH RATES OF HBsAg "a DETERMINANT" VARIABILITY AND IMMUNE ESCAPE MUTATIONS ARE ASSOCIATED WITH HBV REACTIVATION UPON IMMUNOSUPPRESSIVE THERAPY | 1-gen-2013 | Salpini, R; Alteri, C; Cento, V; Ricciardi, A; Maffongelli, G; Pollicita, M; Mirabelli, C; Sarrecchia, C; Sarmati, L; Mastroianni, C; Paoloni, M; Angelico, M; Andreoni, M; Perno, Cf; Svicher, V | |
| KEY GENETIC SIGNATURES IN THE WHOLE pre-S1/Pre-S2/S GENE CORRELATE WITH HBV-INDUCED CARCINOGENESIS BY AFFECTING HBsAg SECRETION AND RELEASE | 1-gen-2013 | Svicher, V; Neumann-Fraune, M; Mirabelli, C; Salpini, R; Cento, V; Di Maio, Vc; Bertoli, A; Alteri, C; Aragri, M; Gori, C; Micheli, V; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf | |
| Key genetic markers in the full-length HBsAg gene correlate with HBV-driven carcinogenesis by affecting HBsAg secretion and release | 1-gen-2013 | Svicher, V; Neumann-Fraune, M; Mirabelli, C; Salpini, R; Cento, V; Di Maio, Vc; Bertoli, A; Alteri, C; Aragri, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Verhejen, J; Perno, Cf | |
| Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure | 1-gen-2013 | Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf | |
| HCV DIVERSITY AND FIBROSIS PROGRESSION: NS5A AND CORE VARIANTS CORRELATE WITH SEVERITY OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION | 1-gen-2013 | Lenci, I; Cucchiarelli, S; Di Maio, Vc; Cento, V; De Luca, F; Milana, M; Antonucci, Fp; Di Paolo, D; Giardina, E; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| NS3-resistance in advanced HCV patients treated with BOC/TRV-based therapy: impact on virological failure of baseline and early time points | 1-gen-2013 | Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Bertoli, A; De Leonardis, F; Madeddu, G; Magni, C; Sarrecchia, C; Nosotti, L; Tortora, A; Di Biagio, A; Nicolini, La; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile